Table 6.
Clinical outcomes.
| Total (n = 42) |
PAPi < 1.3 (n = 20) |
PAPi ≥ 1.3 (n = 22) |
p-Value | |
|---|---|---|---|---|
| Impella upgrade/concomitant use of ECMO | 11 (26%) | 11 (55%) | 0 (0%) | <0.0001 * |
| Suction events | 7 (17%) | 5 (25%) | 2 (9.1%) | 0.2289 |
| Pump thrombosis | 1 (2.4%) | 1 (5.0%) | 0 (0%) | 0.4762 |
| Hemolysis | 20 (48%) | 14 (70%) | 6 (27%) | 0.0124 * |
| Recovery without mechanical circulatory support | 33 (79%) | 17 (85%) | 16 (73%) | 0.4595 |
| Durable left ventricular assist device implantation | 6 (14%) | 1 (5.0%) | 5 (23%) | 0.187 |
| 30-day survival | 34 (81%) | 15 (75%) | 19 (86%) | 0.4454 |
| Survival discharge | 29 (69%) | 10 (50%) | 19 (86%) | 0.0186 * |
ECMO, extracorporeal membrane oxygenation. * p < 0.05 by Mann–Whitney U test or Fisher’s exact test as appropriate.